Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Higuchi, K. Takayanagi, S. Mitarai, M. Aoki, N. Harada, M. Okumura, T. Yoshiyama, H. Ogata, Y. Sekiya, T. Mori (Kiyose, Higashimurayama, Japan). Sequential analysis of interferon-γ release assay results in active tuberculosis patients. Eur Respir J 2009; 34: Suppl. 53, 1692

Member's Comments

No comment yet.

Related content which might interest you: Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007 Interferon-γ release assay tests to rule out active tuberculosis Source: Eur Respir J 2007; 30: 183-184 Year: 2007 The significance of the antigen-specific IFN-γ release assay in vitro for differential diagnosis between sarcoidosis and tuberculosis (TB) patients Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010 False-negative interferon gamma release assay results in active tuberculosis: a TBNET study Source: Eur Respir J 2015; 45: 279-283 Year: 2015 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Comparison of two in vitro IFN-γ assays for detection of latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006 Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Time interval to conversion of interferon-? release assay after exposure to tuberculosis Source: Eur Respir J 2011; 37: 1447-1452 Year: 2011 Frequent detection of discordant results of two interferon-γ release assays in an aged population Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 IFN-γ response on T-cell based assays for the diagnosis of tuberculosis infection in rheumatic patients undergoing anti-TNF-α treatment Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-γ release assays Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Performance of a commercial IFN-γ blood assay for monitoring treatment efficacy in active pulmonary tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Indeterminate test results of T-SPOTTM.TB performed under routine field conditions Source: Eur Respir J 2008; 31: 842-846 Year: 2008 Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test Source: Eur Respir J 2009; 33: 1374-1382 Year: 2009 Novel sequence-based assay for detection of pyrazinamide-resistant mycobacterium tuberculosis in clinical specimens from patients with pulmonary tuberculosis in Russia Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011 Indeterminate IFN-? release assay test results predict poor prognosis of active pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Indeterminate results of a tuberculosis-specific interferon-γ release assay in immunocompromised patients Source: Eur Respir J 2010; 35: 1179-1182 Year: 2010 Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020